Maxcyte (DI) (MXCT)

 173.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 180.00
  • 52 Week Low: 107.50
  • Currency: UK Pounds
  • Shares Issued: 76.59m
  • Volume: 0
  • Market Cap: £132.87m

Regulatory News

Holding(s) in Company 28-May-2020 15:34 RNS
Holding(s) in Company 26-May-2020 17:49 RNS
Holding(s) in Company 26-May-2020 16:22 RNS
Holdings in Company 26-May-2020 15:45 RNS
Result of Special Meeting and Issue of Equity 21-May-2020 13:50 RNS
Poster Presentation on MCY-M11 at ASCO 2020 14-May-2020 07:00 RNS
License Agreement with Caribou Biosciences 07-May-2020 07:00 RNS
Result of Offering 01-May-2020 07:00 RNS
Proposed Offering to raise up to £25.1 mill... 30-Apr-2020 17:39 RNS
Final Results for Year Ended 31 December 2019 21-Apr-2020 07:00 RNS
Business Update Related to COVID-19 Pandemic 09-Apr-2020 07:00 RNS
License Agreement with Allogene Therapeutics 24-Mar-2020 07:00 RNS
Consolidation of Trading Lines 21-Feb-2020 07:00 RNS
AIM Block Admission Return / Total Voting Rights 20-Feb-2020 18:18 RNS
Grant Of Options 24-Jan-2020 16:31 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 173.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 180.00
52 Week Low 107.50
Volume 0
Shares Issued 76.59m
Market Cap £132.87m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Maxcyte (DI) Key Personnel

CEO Doug Doerfler
CFO Ron Holtz

Top of Page